Chlorpheniramine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Chlorpheniramine. Educational only — not medical advice.

Labeled uses

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. Important Limitations of Use : • Not indicated for pediatric patients under 18 years of age [see Use in Specific Populations (8.4 ) ]. • Contraindicated in pediatric patients less than 6 years of age [see Contraindications (4) ]. • Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions (5.1) ], reserve Hydrocodone Polistirex and Chlorpheniramine Polistirex for use in adult patients for whomthe benefits of cough suppression are expected to outweigh the risks, and in whom an adequateassessment of the etiology of the cough has been made.

Source: FDA labeling via NIH DailyMed (set 9445fb20…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.